Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMT vs GSK✓SelectedUSD · GSKWMT vs GSK performance historyLatest closeAs of+1.52%11/20
Stock and ETF performance explorer

WMT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+155.1%
GSK return
+53.4%
Excess return
+101.7%
Maximum drawdown
-23.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.5%-0.1%+1.6%+1.5%
7D-0.1%-5.3%+5.2%+0.8%
30D+8.6%-3.7%+12.3%+9.2%
3M+23.5%-7.3%+30.8%+24.8%
6M-2.0%-4.2%+2.3%-1.4%
YTD+15.6%+0.9%+14.7%+15.9%
1Y+20.5%+7.3%+13.2%+20.2%
3Y+155.1%+52.7%+102.3%+139.0%
All+155.1%+53.4%+101.7%+139.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling